We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.
- Authors
Nabholtz, Jean-Marc; Falkson, Carla; Campos, Daniel; Szanto, Janos; Martin, Miguel; Chan, Stephen; Pienkowski, Tadeuz; Zaluski, Jerzy; Pinter, Tamas; Krzakowski, Maciej; Vorobiof, Daniel; Leonard, Robert; Kennedy, Ian; Azli, Nacer; Murawsky, Michael; Riva, Alessandro; Pouillart, Pierre; TAX 306 Study Group
- Abstract
This randomized, multicenter, phase III study compared doxorubicin and docetaxel (AT) with doxorubicin and cyclophosphamide (AC) as first-line chemotherapy (CT) in metastatic breast cancer (MBC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Vol 21, Issue 6, p968
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2003.04.040